Literature DB >> 26560242

Smart linkers in polymer-drug conjugates for tumor-targeted delivery.

Minglu Chang1, Fang Zhang1, Ting Wei1, Tiantian Zuo1, Yuanyuan Guan1, Guimei Lin1, Wei Shao1.   

Abstract

To achieve effective chemotherapy, many types of drug delivery systems have been developed for the specific environments in tumor tissues. Polymer-drug conjugates are increasingly used in tumor therapy due to several significant advantages over traditional delivery systems. In the fabrication of polymer-drug conjugates, a smart linker is an important component that joins two fragments or molecules together and can be cleared by a specific stimulus, which results in targeted drug delivery and controlled release. By regulating the conjugation between the drug and the nanocarriers, stimulus-sensitive systems based on smart linkers can offer high payloads, certified stability, controlled release and targeted delivery. In this review, we summarize the current state of smart linkers (e.g. disulfide, hydrazone, peptide, azo) used recently in various polymer-drug conjugate-based delivery systems with a primary focus on their sophisticated design principles and drug delivery mechanisms as well as in vivo processes.

Entities:  

Keywords:  Chemotherapy; controlled release; delivery system; nanomedicine; stimulus-sensitive

Mesh:

Substances:

Year:  2015        PMID: 26560242     DOI: 10.3109/1061186X.2015.1108324

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  12 in total

1.  Total drug quantification in prodrugs using an automated elemental analyzer.

Authors:  Yingwen Hu; David M Stevens; Sonny Man; Rachael M Crist; Jeffrey D Clogston
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 4.617

2.  Inflammation-Responsive Drug-Conjugated Dextran Nanoparticles Enhance Anti-Inflammatory Drug Efficacy.

Authors:  Sangeun Lee; Alexandra Stubelius; Naomi Hamelmann; Vincent Tran; Adah Almutairi
Journal:  ACS Appl Mater Interfaces       Date:  2018-11-13       Impact factor: 9.229

3.  Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections.

Authors:  Fang-Yi Su; Selvi Srinivasan; Brian Lee; Jasmin Chen; Anthony J Convertine; Timothy Eoin West; Daniel M Ratner; Shawn J Skerrett; Patrick S Stayton
Journal:  J Control Release       Date:  2018-08-09       Impact factor: 9.776

Review 4.  Polymer-Drug Conjugate, a Potential Therapeutic to Combat Breast and Lung Cancer.

Authors:  Sibusiso Alven; Xhamla Nqoro; Buhle Buyana; Blessing A Aderibigbe
Journal:  Pharmaceutics       Date:  2020-04-29       Impact factor: 6.321

5.  Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment.

Authors:  Natalia Oddone; Frank Boury; Emmanuel Garcion; Andreas M Grabrucker; M Carmen Martinez; Federica Da Ros; Anna Janaszewska; Flavio Forni; Maria Angela Vandelli; Giovanni Tosi; Barbara Ruozi; Jason T Duskey
Journal:  Front Pharmacol       Date:  2020-05-04       Impact factor: 5.810

Review 6.  Recent Progress and Advances in Stimuli-Responsive Polymers for Cancer Therapy.

Authors:  N Vijayakameswara Rao; Hyewon Ko; Jeongjin Lee; Jae Hyung Park
Journal:  Front Bioeng Biotechnol       Date:  2018-08-13

Review 7.  Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis.

Authors:  G Y Wang; S L Rayner; R Chung; B Y Shi; X J Liang
Journal:  Mater Today Bio       Date:  2020-05-04

Review 8.  On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.

Authors:  Eirinaios I Vrettos; Gábor Mező; Andreas G Tzakos
Journal:  Beilstein J Org Chem       Date:  2018-04-26       Impact factor: 2.883

9.  Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.

Authors:  Shiran Ferber; Galia Tiram; Ana Sousa-Herves; Anat Eldar-Boock; Adva Krivitsky; Anna Scomparin; Eilam Yeini; Paula Ofek; Dikla Ben-Shushan; Laura Isabel Vossen; Kai Licha; Rachel Grossman; Zvi Ram; Jack Henkin; Eytan Ruppin; Noam Auslander; Rainer Haag; Marcelo Calderón; Ronit Satchi-Fainaro
Journal:  Elife       Date:  2017-10-04       Impact factor: 8.140

Review 10.  Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies.

Authors:  Paul Hoppenz; Sylvia Els-Heindl; Annette G Beck-Sickinger
Journal:  Front Chem       Date:  2020-07-07       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.